Filing Details

Accession Number:
0001209191-18-034231
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-30 18:02:53
Reporting Period:
2018-05-30
Accepted Time:
2018-05-30 18:02:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1704255 James Engelhart C/O Biohaven Pharmaceuticals, Inc.
234 Church Street
New Haven CT 06510
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2018-05-30 5,000 $0.61 5,000 No 4 M Direct
Common Shares Disposition 2018-05-30 5,000 $35.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Disposition 2018-05-30 5,000 $0.00 5,000 $0.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,500 2024-11-25 No 4 M Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Immediately exercisable.